Idorsia Ltd. (United States)

Idorsia is a Swiss biopharmaceutical company developing innovative medicines for unmet medical needs. The company created QUVIVIQ (daridorexant), a dual orexin receptor antagonist for treating insomnia in adults. Idorsia’s research focuses on central nervous system disorders, rare diseases, and cardiovascular conditions where new therapeutic approaches are needed.